HomeGeneticsConditionAllan-Herndon-Dudley syndrome
Back to Condition
Allan-Herndon-Dudley syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Allan-Herndon-Dudley syndrome

Allan-Herndon-Dudley syndrome is a rare, X-linked genetic disorder that impairs brain development, resulting in intellectual disability and significant movement challenges.

Overview

Allan-Herndon-Dudley syndrome is a rare disorder of brain development that causes moderate to severe intellectual disability and problems with movement. This condition occurs exclusively in males and disrupts development from before birth. Although affected males have impaired speech and a limited ability to communicate, they often appear to enjoy social interaction.

Symptoms

Most children with the syndrome experience a range of physical and neurological challenges:

  • Hypotonia: Weak muscle tone in infancy.
  • Muscle hypoplasia: Underdevelopment of many muscles.
  • Mobility issues: Abnormal muscle stiffness (spasticity), muscle weakness, and involuntary movements of the arms and legs.
  • Contractures: Joint deformities that develop with age, restricting movement.
  • Developmental impact: Many individuals are unable to walk independently and become wheelchair-bound by adulthood.

Causes

The syndrome is caused by mutations in the SLC16A2 gene (also known as MCT8). This gene provides instructions for creating a protein critical for nervous system development. The protein is responsible for transporting the hormone triiodothyronine (T3) into nerve cells in the developing brain.

When the SLC16A2 protein is dysfunctional, it cannot effectively transport T3 into nerve cells. This leads to:

  • Disrupted brain development due to a lack of T3 in specific brain regions.
  • Intellectual disability and movement disorders.
  • Increased levels of T3 in the bloodstream, which may be toxic to other organs.

Inheritance

This condition follows an X-linked recessive pattern of inheritance. Because the gene is located on the X chromosome, males (who have only one X chromosome) are affected if they inherit a single mutated copy. Females (who have two X chromosomes) typically act as carriers; they can pass the gene to their children but usually do not experience symptoms themselves.

Frequently Asked Questions

definitive diagnosis is made by identifying a pathogenic mutation in the SLC16A2 gene through targeted genetic testing (often via a next‑generation sequencing panel for X‑linked disorders). Because the syndrome causes abnormal thyroid hormone transport, serum levels of free T3, total T3, and T4 are typically elevated, while TSH may be normal or low. Neuroimaging (MRI) is usually performed to assess brain structure and rule out other causes of developmental delay, but it is not diagnostic for the syndrome itself. A combination of genetic confirmation and characteristic thyroid hormone profile establishes the diagnosis.
Most affected males experience progressive motor decline; many become wheelchair‑bound by adolescence. Early intervention can delay the onset of severe contractures and improve functional mobility, but the degree of independence varies. Some individuals may achieve assisted ambulation with orthotic devices or powered mobility aids, while others rely on full wheelchair support. Long‑term care planning should involve occupational therapy to optimize daily living skills and assistive technology to enhance independence.
Early, multidisciplinary intervention is key. Physical therapy focusing on stretching, range‑of‑motion exercises, and strengthening can help maintain muscle tone and prevent contractures. Pharmacologic options include oral baclofen or diazepam to reduce spasticity, and intrathecal baclofen pumps may be considered for severe cases. Orthopedic evaluation for joint contractures is important; serial casting, splinting, or surgical release may be required. Regular reassessment ensures that therapy is adjusted to the child’s changing needs.
Speech and language therapy should begin early, even if verbal output is minimal. Therapists can introduce augmentative and alternative communication (AAC) devices such as picture exchange systems, speech‑generating tablets, or simple sign language. Encouraging social play with peers, using non‑verbal cues, and maintaining a supportive, patient environment help the child feel included. Consistent use of AAC tools across home, school, and therapy settings maximizes effectiveness.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss